Skip to main content
. 2018 Apr 17;9(29):20658–20669. doi: 10.18632/oncotarget.25057

Table 2. List of all candidate miRNAs from the discovery phase stratified for BC invasiveness that were selected for replica/validation phase.

Mean read counts log2 Fold Change adj P (FDR) PP
Candidate miRNAs for MIBC
amiR-21-5p 29223 1.42 0.01 0.85
amiR-106b-3p 130 2.53 0.00 0.85
bmiR-30a-5p 19453 –1.80 0.05 0.85
blet-7c-5p 1497 –1.62 0.02 0.85
bmiR-486-5p 819 3.68 0.01 <0.70
cmiR-205-5p 376 2.97 0.00 0.9
miR-451a 1004 3.40 0.04 <0.70
miR-25-3p 588 1.99 0.02 <0.70
miR-7-1-5p 518 3.32 0.05 0.85
miR-146a-5p 420 2.49 0.04 <0.70
Candidate miRNAs for NMIBC G1 + G2
dmiR-30c-2-5p 2106 –0.73 0.00 <0.70
dmiR-151a-3p 2873 0.34 0.02 <0.70
bmiR-30a-5p 27229 –0.63 0.00 0.73
blet-7c-5p 2644 –0.43 0.04 0.71
bmiR-486-5p 1868 1.94 0.02 <0.70
cmiR-205-5p 479 1.82 0.00 0.73
let-7i-5p 5038 0.55 0.03 <0.70
Candidate miRNAs for NMIBC G3
amiR-21-5p 38624 0.87 0.03 0.76
amiR-106b-3p 184 2.30 0.00 0.88
bmiR-30a-5p 29232 –1.67 0.00 0.76
blet-7c-5p 2939 –1.17 0.03 <0.70
bmiR-486-5p 2918 3.14 0.00 <0.70
dmiR-30c-2-5p 2241 –1.47 0.01 <0.70
dmiR-151a-3p 3884 0.51 0.03 <0.70
miR-10b-5p 28018 –1.88 0.00 0.85
miR-148b-3p 660 0.95 0.00 0.85
miR-183-5p 1414 1.50 0.00 <0.70
miR-185-5p 381 2.10 0.00 0.76
miR-200c-3p 9145 1.11 0.00 0.76
miR-224-5p 488 2.97 0.00 0.79
miR-4448 7834 –2.27 0.01 <0.70
miR-98-5p 459 1.01 0.01 0.79

Abbreviations: FDR false discovery rate, PP predictive power, MIBC muscle-invasive bladder cancer, NMIBC non-muscle invasive bladder cancer.

amiRNAs in common between NMIBC G3 and MIBC.

bmiRNAs in common among NMIBC G1 + G2, NMIBC G3, and MIBC.

cmiRNAs in common between NMIBC G1 + G2 and MIBC.

dmiRNAs in common between NMIBC G1 + G2 and NMIBC G3.